Rapid PE Triage and Notification (PETN) vs Cardiologs Holter Platform
AI Verdict
Choose Rapid PE Triage and Notification (PETN) if…
Choose Rapid PE Triage and Notification (PETN) if your priority is the immediate, AI-driven identification and notification of suspected central pulmonary embolisms from CTPA images. This tool is ideal for emergency departments and critical care settings that require rapid detection and streamlined workflows for life-threatening conditions to accelerate patient care pathways.
View Rapid PE Triage and Notification (PETN) →Choose Cardiologs Holter Platform if…
Choose the Cardiologs Holter Platform if your primary need is efficient, AI-powered analysis of Holter ECGs for comprehensive arrhythmia detection. This cloud-based solution is best suited for cardiology practices and diagnostic centers aiming to significantly reduce Holter analysis time and gain accurate insights into over 20 types of arrhythmias, enabling faster and more accessible cardiac diagnostics.
View Cardiologs Holter Platform →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid PE Triage and Notification (PETN) | Cardiologs Holter Platform |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform. | Cloud |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiologs Holter PlatformTool B offers a cloud-based platform with anytime, anywhere access and vendor-neutral compatibility, which enhances flexibility for users. Its focus on reducing analysis time by 42% and generating easy-to-read reports directly addresses user efficiency and experience.
Clinical Value
TieBoth tools are FDA-cleared and provide significant clinical value in their respective domains. Tool A offers rapid identification and notification for acute, life-threatening pulmonary embolisms, while Tool B provides comprehensive and efficient detection of over 20 types of arrhythmias. Both are backed by clinical validation studies.
Pricing & Value
Cardiologs Holter PlatformWhile neither tool provides publicly disclosed pricing, Tool B explicitly states a 'pay per ECG' model, which offers a clearer and potentially more predictable cost structure for healthcare providers. Tool A's 'enterprise-level licensing' is less defined, making value assessment more opaque.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness with HIPAA compliance, BAA, and FDA clearance. Tool A offers flexible deployment options (on-premise or cloud), while Tool B, backed by Philips, provides secure cloud hosting on ISO/IEC 27001 certified AWS servers and specific EMR integration with Philips IntelliBridge Enterprise.
Innovation
Cardiologs Holter PlatformTool B leverages AI-powered deep learning for comprehensive detection of over 20 types of arrhythmias, combined with a vendor-neutral cloud platform and a quantifiable 42% reduction in analysis time. This demonstrates a broader technological and process innovation in cardiac diagnostics.
Support & Docs
Cardiologs Holter PlatformWhile specific documentation details are not publicly available for either, Tool B benefits significantly from being part of Philips, a global healthcare technology leader. Philips' established and extensive support infrastructure typically translates to more robust and reliable customer support resources for its products.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid PE Triage and Notification (PETN) | Cardiologs Holter Platform |
|---|---|---|
| Name | Rapid PE Triage and Notification (PETN) | Cardiologs Holter Platform |
| Company | RapidAI (formerly iSchemaView) | Philips France Commercial |
| Description | AI-powered software that analyzes CTPA images to rapidly identify and notify clinicians of suspected central pulmonary embolisms, streamlining workflow and accelerating patient care pathways. | AI-powered, cloud-based solution for fast and accurate Holter ECG analysis, designed to detect over 20 types of arrhythmias and streamline cardiac diagnostics for healthcare professionals. |
| Key Features | AI/ML module for CTPA image analysis, Detection of suspected central pulmonary embolism (PE), Workflow triage and prioritization, Real-time notifications to clinicians (PACS, email, mobile app), Compressed preview images (not for diagnostic use), Operates in parallel with standard of care, Integration within the Rapid Platform, Mobile and desktop application access | AI-powered deep learning technology for ECG analysis, Cloud-based platform for anytime, anywhere access, Vendor-neutral compatibility with multiple Holter devices, Reduces Holter analysis time by approximately 42%, Detects over 20 types of arrhythmias, Integration with Electronic Medical Record (EMR) systems (Philips IntelliBridge Enterprise), Secure data hosting on ISO/IEC 27001 certified AWS servers, Generates easy-to-read, automatically enriched reports |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Rapid PE Triage and Notification (PETN) and Cardiologs Holter Platform.